DDrare
Disease
Drug
Target Gene/Pathway
お問合せ先
EN
Drug
Description in Trials
/
DrugBank
/
KEGG DRUG
Search
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Other
Search results
10
50
100
ALL
descriptions per page:
Showing 1 to 10 of 39 descriptions
Filter by
Reset
|
No.
薬物名（臨床試験情報から抽出）
DrugBank
KEGG DRUG
KEGG GENES
KEGG PATHWAY
指定難病告示番号
1
15N2-
tofacitinib
1件:
Tofacitinib
Tofacitinib
(PMS-
tofacitinib
)
1件:
Tofacitinib
Tofacitinib
(
Tofacitinib
)
💬
1. 15N2-
tofacitinib
×
Name
Other Names
Tofacitinib
Tofacitinib (USAN)
Tasocitinib
トファシチニブ
タソシチニブ
4件:
JAK1
JAK1
,
JAK2
,
JAK3
,
TYK2
💬
1. 15N2-
tofacitinib
×
Name
Full Name
JAK1
Janus kinase 1
JAK2
Janus kinase 2
JAK3
Janus kinase 3
TYK2
tyrosine kinase 2
37件:
AGE-RAGE signaling pathway in diabetic complications
AGE-RAGE signaling pathway in diabetic complications
,
Adipocytokine signaling pathway
,
Chemical carcinogenesis - receptor activation
,
Chemokine signaling pathway
,
Cholinergic synapse
,
Coronavirus disease - COVID-19
,
EGFR tyrosine kinase inhibitor resistance
,
Epstein-Barr virus infection
,
Growth hormone synthesis, secretion and action
,
Hepatitis B
,
Hepatitis C
,
Herpes simplex virus 1 infection
,
Human T-cell leukemia virus 1 infection
,
Human cytomegalovirus infection
,
Human papillomavirus infection
,
Influenza A
,
JAK-STAT signaling pathway
,
Kaposi sarcoma-associated herpesvirus infection
,
Leishmaniasis
,
Lipid and atherosclerosis
,
Measles
,
NOD-like receptor signaling pathway
,
Necroptosis
,
Non-small cell lung cancer
,
Osteoclast differentiation
,
PD-L1 expression and PD-1 checkpoint pathway in cancer
,
PI3K-Akt signaling pathway
,
Pancreatic cancer
,
Pathways in cancer
,
Primary immunodeficiency
,
Prolactin signaling pathway
,
Signaling pathways regulating pluripotency of stem cells
,
Th1 and Th2 cell differentiation
,
Th17 cell differentiation
,
Toxoplasmosis
,
Tuberculosis
,
Viral carcinogenesis
💬
37件:
AGE-RAGE signaling pathway in diabetic complications
,
Adipocytokine signaling pathway
,
Chemical
...
1件:
97
97
💬
1. 15N2-
tofacitinib
×
告示番号
日本語名
英語名
97
潰瘍性大腸炎
Ulcerative colitis
2
Chong Kun Dang
Tofacitinib
Tablet
1件:
Tofacitinib
Tofacitinib
(PMS-
tofacitinib
)
1件:
Tofacitinib
Tofacitinib
(
Tofacitinib
)
💬
2. Chong Kun Dang
Tofacitinib
Tablet
×
Name
Other Names
Tofacitinib
Tofacitinib (USAN)
Tasocitinib
トファシチニブ
タソシチニブ
4件:
JAK1
JAK1
,
JAK2
,
JAK3
,
TYK2
💬
2. Chong Kun Dang
Tofacitinib
Tablet
×
Name
Full Name
JAK1
Janus kinase 1
JAK2
Janus kinase 2
JAK3
Janus kinase 3
TYK2
tyrosine kinase 2
37件:
AGE-RAGE signaling pathway in diabetic complications
AGE-RAGE signaling pathway in diabetic complications
,
Adipocytokine signaling pathway
,
Chemical carcinogenesis - receptor activation
,
Chemokine signaling pathway
,
Cholinergic synapse
,
Coronavirus disease - COVID-19
,
EGFR tyrosine kinase inhibitor resistance
,
Epstein-Barr virus infection
,
Growth hormone synthesis, secretion and action
,
Hepatitis B
,
Hepatitis C
,
Herpes simplex virus 1 infection
,
Human T-cell leukemia virus 1 infection
,
Human cytomegalovirus infection
,
Human papillomavirus infection
,
Influenza A
,
JAK-STAT signaling pathway
,
Kaposi sarcoma-associated herpesvirus infection
,
Leishmaniasis
,
Lipid and atherosclerosis
,
Measles
,
NOD-like receptor signaling pathway
,
Necroptosis
,
Non-small cell lung cancer
,
Osteoclast differentiation
,
PD-L1 expression and PD-1 checkpoint pathway in cancer
,
PI3K-Akt signaling pathway
,
Pancreatic cancer
,
Pathways in cancer
,
Primary immunodeficiency
,
Prolactin signaling pathway
,
Signaling pathways regulating pluripotency of stem cells
,
Th1 and Th2 cell differentiation
,
Th17 cell differentiation
,
Toxoplasmosis
,
Tuberculosis
,
Viral carcinogenesis
💬
37件:
AGE-RAGE signaling pathway in diabetic complications
,
Adipocytokine signaling pathway
,
Chemical
...
1件:
46
46
💬
2. Chong Kun Dang
Tofacitinib
Tablet
×
告示番号
日本語名
英語名
46
悪性関節リウマチ
Malignant rheumatoid arthritis
3
CP-690,550 (
tofacitinib
)
1件:
Tofacitinib
Tofacitinib
(PMS-
tofacitinib
)
1件:
Tofacitinib
Tofacitinib
(
Tofacitinib
)
💬
3. CP-690,550 (
tofacitinib
)
×
Name
Other Names
Tofacitinib
Tofacitinib (USAN)
Tasocitinib
トファシチニブ
タソシチニブ
4件:
JAK1
JAK1
,
JAK2
,
JAK3
,
TYK2
💬
3. CP-690,550 (
tofacitinib
)
×
Name
Full Name
JAK1
Janus kinase 1
JAK2
Janus kinase 2
JAK3
Janus kinase 3
TYK2
tyrosine kinase 2
37件:
AGE-RAGE signaling pathway in diabetic complications
AGE-RAGE signaling pathway in diabetic complications
,
Adipocytokine signaling pathway
,
Chemical carcinogenesis - receptor activation
,
Chemokine signaling pathway
,
Cholinergic synapse
,
Coronavirus disease - COVID-19
,
EGFR tyrosine kinase inhibitor resistance
,
Epstein-Barr virus infection
,
Growth hormone synthesis, secretion and action
,
Hepatitis B
,
Hepatitis C
,
Herpes simplex virus 1 infection
,
Human T-cell leukemia virus 1 infection
,
Human cytomegalovirus infection
,
Human papillomavirus infection
,
Influenza A
,
JAK-STAT signaling pathway
,
Kaposi sarcoma-associated herpesvirus infection
,
Leishmaniasis
,
Lipid and atherosclerosis
,
Measles
,
NOD-like receptor signaling pathway
,
Necroptosis
,
Non-small cell lung cancer
,
Osteoclast differentiation
,
PD-L1 expression and PD-1 checkpoint pathway in cancer
,
PI3K-Akt signaling pathway
,
Pancreatic cancer
,
Pathways in cancer
,
Primary immunodeficiency
,
Prolactin signaling pathway
,
Signaling pathways regulating pluripotency of stem cells
,
Th1 and Th2 cell differentiation
,
Th17 cell differentiation
,
Toxoplasmosis
,
Tuberculosis
,
Viral carcinogenesis
💬
37件:
AGE-RAGE signaling pathway in diabetic complications
,
Adipocytokine signaling pathway
,
Chemical
...
2件:
46
46
,
107
💬
3. CP-690,550 (
tofacitinib
)
×
告示番号
日本語名
英語名
46
悪性関節リウマチ
Malignant rheumatoid arthritis
107
若年性特発性関節炎
Juvenile idiopathic arthritis
4
In double-blind phase: treatment with
tofacitinib
1件:
Tofacitinib
Tofacitinib
(PMS-
tofacitinib
)
1件:
Tofacitinib
Tofacitinib
(
Tofacitinib
)
💬
4. In double-blind phase: treatment with
tofacitinib
×
Name
Other Names
Tofacitinib
Tofacitinib (USAN)
Tasocitinib
トファシチニブ
タソシチニブ
4件:
JAK1
JAK1
,
JAK2
,
JAK3
,
TYK2
💬
4. In double-blind phase: treatment with
tofacitinib
×
Name
Full Name
JAK1
Janus kinase 1
JAK2
Janus kinase 2
JAK3
Janus kinase 3
TYK2
tyrosine kinase 2
37件:
AGE-RAGE signaling pathway in diabetic complications
AGE-RAGE signaling pathway in diabetic complications
,
Adipocytokine signaling pathway
,
Chemical carcinogenesis - receptor activation
,
Chemokine signaling pathway
,
Cholinergic synapse
,
Coronavirus disease - COVID-19
,
EGFR tyrosine kinase inhibitor resistance
,
Epstein-Barr virus infection
,
Growth hormone synthesis, secretion and action
,
Hepatitis B
,
Hepatitis C
,
Herpes simplex virus 1 infection
,
Human T-cell leukemia virus 1 infection
,
Human cytomegalovirus infection
,
Human papillomavirus infection
,
Influenza A
,
JAK-STAT signaling pathway
,
Kaposi sarcoma-associated herpesvirus infection
,
Leishmaniasis
,
Lipid and atherosclerosis
,
Measles
,
NOD-like receptor signaling pathway
,
Necroptosis
,
Non-small cell lung cancer
,
Osteoclast differentiation
,
PD-L1 expression and PD-1 checkpoint pathway in cancer
,
PI3K-Akt signaling pathway
,
Pancreatic cancer
,
Pathways in cancer
,
Primary immunodeficiency
,
Prolactin signaling pathway
,
Signaling pathways regulating pluripotency of stem cells
,
Th1 and Th2 cell differentiation
,
Th17 cell differentiation
,
Toxoplasmosis
,
Tuberculosis
,
Viral carcinogenesis
💬
37件:
AGE-RAGE signaling pathway in diabetic complications
,
Adipocytokine signaling pathway
,
Chemical
...
1件:
107
107
💬
4. In double-blind phase: treatment with
tofacitinib
×
告示番号
日本語名
英語名
107
若年性特発性関節炎
Juvenile idiopathic arthritis
5
In open-label phase: treatment with
tofacitinib
1件:
Tofacitinib
Tofacitinib
(PMS-
tofacitinib
)
1件:
Tofacitinib
Tofacitinib
(
Tofacitinib
)
💬
5. In open-label phase: treatment with
tofacitinib
×
Name
Other Names
Tofacitinib
Tofacitinib (USAN)
Tasocitinib
トファシチニブ
タソシチニブ
4件:
JAK1
JAK1
,
JAK2
,
JAK3
,
TYK2
💬
5. In open-label phase: treatment with
tofacitinib
×
Name
Full Name
JAK1
Janus kinase 1
JAK2
Janus kinase 2
JAK3
Janus kinase 3
TYK2
tyrosine kinase 2
37件:
AGE-RAGE signaling pathway in diabetic complications
AGE-RAGE signaling pathway in diabetic complications
,
Adipocytokine signaling pathway
,
Chemical carcinogenesis - receptor activation
,
Chemokine signaling pathway
,
Cholinergic synapse
,
Coronavirus disease - COVID-19
,
EGFR tyrosine kinase inhibitor resistance
,
Epstein-Barr virus infection
,
Growth hormone synthesis, secretion and action
,
Hepatitis B
,
Hepatitis C
,
Herpes simplex virus 1 infection
,
Human T-cell leukemia virus 1 infection
,
Human cytomegalovirus infection
,
Human papillomavirus infection
,
Influenza A
,
JAK-STAT signaling pathway
,
Kaposi sarcoma-associated herpesvirus infection
,
Leishmaniasis
,
Lipid and atherosclerosis
,
Measles
,
NOD-like receptor signaling pathway
,
Necroptosis
,
Non-small cell lung cancer
,
Osteoclast differentiation
,
PD-L1 expression and PD-1 checkpoint pathway in cancer
,
PI3K-Akt signaling pathway
,
Pancreatic cancer
,
Pathways in cancer
,
Primary immunodeficiency
,
Prolactin signaling pathway
,
Signaling pathways regulating pluripotency of stem cells
,
Th1 and Th2 cell differentiation
,
Th17 cell differentiation
,
Toxoplasmosis
,
Tuberculosis
,
Viral carcinogenesis
💬
37件:
AGE-RAGE signaling pathway in diabetic complications
,
Adipocytokine signaling pathway
,
Chemical
...
1件:
107
107
💬
5. In open-label phase: treatment with
tofacitinib
×
告示番号
日本語名
英語名
107
若年性特発性関節炎
Juvenile idiopathic arthritis
6
Tofacitinib
1件:
Tofacitinib
Tofacitinib
(PMS-
tofacitinib
)
1件:
Tofacitinib
Tofacitinib
(
Tofacitinib
)
💬
6.
Tofacitinib
×
Name
Other Names
Tofacitinib
Tofacitinib (USAN)
Tasocitinib
トファシチニブ
タソシチニブ
4件:
JAK1
JAK1
,
JAK2
,
JAK3
,
TYK2
💬
6.
Tofacitinib
×
Name
Full Name
JAK1
Janus kinase 1
JAK2
Janus kinase 2
JAK3
Janus kinase 3
TYK2
tyrosine kinase 2
37件:
AGE-RAGE signaling pathway in diabetic complications
AGE-RAGE signaling pathway in diabetic complications
,
Adipocytokine signaling pathway
,
Chemical carcinogenesis - receptor activation
,
Chemokine signaling pathway
,
Cholinergic synapse
,
Coronavirus disease - COVID-19
,
EGFR tyrosine kinase inhibitor resistance
,
Epstein-Barr virus infection
,
Growth hormone synthesis, secretion and action
,
Hepatitis B
,
Hepatitis C
,
Herpes simplex virus 1 infection
,
Human T-cell leukemia virus 1 infection
,
Human cytomegalovirus infection
,
Human papillomavirus infection
,
Influenza A
,
JAK-STAT signaling pathway
,
Kaposi sarcoma-associated herpesvirus infection
,
Leishmaniasis
,
Lipid and atherosclerosis
,
Measles
,
NOD-like receptor signaling pathway
,
Necroptosis
,
Non-small cell lung cancer
,
Osteoclast differentiation
,
PD-L1 expression and PD-1 checkpoint pathway in cancer
,
PI3K-Akt signaling pathway
,
Pancreatic cancer
,
Pathways in cancer
,
Primary immunodeficiency
,
Prolactin signaling pathway
,
Signaling pathways regulating pluripotency of stem cells
,
Th1 and Th2 cell differentiation
,
Th17 cell differentiation
,
Toxoplasmosis
,
Tuberculosis
,
Viral carcinogenesis
💬
37件:
AGE-RAGE signaling pathway in diabetic complications
,
Adipocytokine signaling pathway
,
Chemical
...
15件:
11
11
,
40
,
44
,
46
,
49
,
50
,
51
,
53
,
65
,
84
,
96
,
97
,
107
,
271
,
300
💬
6.
Tofacitinib
×
告示番号
日本語名
英語名
11
重症筋無力症
Myasthenia gravis
40
高安動脈炎;大動脈炎症候群
Takayasu arteritis
44
多発血管炎性肉芽腫症;ウェゲナー肉芽腫症
Wegener granulomatosis
46
悪性関節リウマチ
Malignant rheumatoid arthritis
49
全身性エリテマトーデス
Systemic lupus erythematosus
50
皮膚筋炎／多発性筋炎
Dermatomyositis
51
全身性強皮症
Scleroderma
53
シェーグレン症候群
Sjogren syndrome
65
原発性免疫不全症候群
Primary immunodeficiency
84
サルコイドーシス
Sarcoidosis
96
クローン病;回腸末端炎
Crohn disease
97
潰瘍性大腸炎
Ulcerative colitis
107
若年性特発性関節炎
Juvenile idiopathic arthritis
271
強直性脊椎炎
Ankylosing spondylitis
300
IgG4関連疾患
IgG4-related disease
7
Tofacitinib
(CP-690,550)
1件:
Tofacitinib
Tofacitinib
(PMS-
tofacitinib
)
1件:
Tofacitinib
Tofacitinib
(
Tofacitinib
)
💬
7.
Tofacitinib
(CP-690,550)
×
Name
Other Names
Tofacitinib
Tofacitinib (USAN)
Tasocitinib
トファシチニブ
タソシチニブ
4件:
JAK1
JAK1
,
JAK2
,
JAK3
,
TYK2
💬
7.
Tofacitinib
(CP-690,550)
×
Name
Full Name
JAK1
Janus kinase 1
JAK2
Janus kinase 2
JAK3
Janus kinase 3
TYK2
tyrosine kinase 2
37件:
AGE-RAGE signaling pathway in diabetic complications
AGE-RAGE signaling pathway in diabetic complications
,
Adipocytokine signaling pathway
,
Chemical carcinogenesis - receptor activation
,
Chemokine signaling pathway
,
Cholinergic synapse
,
Coronavirus disease - COVID-19
,
EGFR tyrosine kinase inhibitor resistance
,
Epstein-Barr virus infection
,
Growth hormone synthesis, secretion and action
,
Hepatitis B
,
Hepatitis C
,
Herpes simplex virus 1 infection
,
Human T-cell leukemia virus 1 infection
,
Human cytomegalovirus infection
,
Human papillomavirus infection
,
Influenza A
,
JAK-STAT signaling pathway
,
Kaposi sarcoma-associated herpesvirus infection
,
Leishmaniasis
,
Lipid and atherosclerosis
,
Measles
,
NOD-like receptor signaling pathway
,
Necroptosis
,
Non-small cell lung cancer
,
Osteoclast differentiation
,
PD-L1 expression and PD-1 checkpoint pathway in cancer
,
PI3K-Akt signaling pathway
,
Pancreatic cancer
,
Pathways in cancer
,
Primary immunodeficiency
,
Prolactin signaling pathway
,
Signaling pathways regulating pluripotency of stem cells
,
Th1 and Th2 cell differentiation
,
Th17 cell differentiation
,
Toxoplasmosis
,
Tuberculosis
,
Viral carcinogenesis
💬
37件:
AGE-RAGE signaling pathway in diabetic complications
,
Adipocytokine signaling pathway
,
Chemical
...
1件:
96
96
💬
7.
Tofacitinib
(CP-690,550)
×
告示番号
日本語名
英語名
96
クローン病;回腸末端炎
Crohn disease
8
Tofacitinib
(Xeljanz)
1件:
Tofacitinib
Tofacitinib
(PMS-
tofacitinib
)
1件:
Tofacitinib
Tofacitinib
(
Tofacitinib
)
💬
8.
Tofacitinib
(Xeljanz)
×
Name
Other Names
Tofacitinib
Tofacitinib (USAN)
Tasocitinib
トファシチニブ
タソシチニブ
4件:
JAK1
JAK1
,
JAK2
,
JAK3
,
TYK2
💬
8.
Tofacitinib
(Xeljanz)
×
Name
Full Name
JAK1
Janus kinase 1
JAK2
Janus kinase 2
JAK3
Janus kinase 3
TYK2
tyrosine kinase 2
37件:
AGE-RAGE signaling pathway in diabetic complications
AGE-RAGE signaling pathway in diabetic complications
,
Adipocytokine signaling pathway
,
Chemical carcinogenesis - receptor activation
,
Chemokine signaling pathway
,
Cholinergic synapse
,
Coronavirus disease - COVID-19
,
EGFR tyrosine kinase inhibitor resistance
,
Epstein-Barr virus infection
,
Growth hormone synthesis, secretion and action
,
Hepatitis B
,
Hepatitis C
,
Herpes simplex virus 1 infection
,
Human T-cell leukemia virus 1 infection
,
Human cytomegalovirus infection
,
Human papillomavirus infection
,
Influenza A
,
JAK-STAT signaling pathway
,
Kaposi sarcoma-associated herpesvirus infection
,
Leishmaniasis
,
Lipid and atherosclerosis
,
Measles
,
NOD-like receptor signaling pathway
,
Necroptosis
,
Non-small cell lung cancer
,
Osteoclast differentiation
,
PD-L1 expression and PD-1 checkpoint pathway in cancer
,
PI3K-Akt signaling pathway
,
Pancreatic cancer
,
Pathways in cancer
,
Primary immunodeficiency
,
Prolactin signaling pathway
,
Signaling pathways regulating pluripotency of stem cells
,
Th1 and Th2 cell differentiation
,
Th17 cell differentiation
,
Toxoplasmosis
,
Tuberculosis
,
Viral carcinogenesis
💬
37件:
AGE-RAGE signaling pathway in diabetic complications
,
Adipocytokine signaling pathway
,
Chemical
...
1件:
46
46
💬
8.
Tofacitinib
(Xeljanz)
×
告示番号
日本語名
英語名
46
悪性関節リウマチ
Malignant rheumatoid arthritis
9
Tofacitinib
(Xeljanz®)
1件:
Tofacitinib
Tofacitinib
(PMS-
tofacitinib
)
1件:
Tofacitinib
Tofacitinib
(
Tofacitinib
)
💬
9.
Tofacitinib
(Xeljanz®)
×
Name
Other Names
Tofacitinib
Tofacitinib (USAN)
Tasocitinib
トファシチニブ
タソシチニブ
4件:
JAK1
JAK1
,
JAK2
,
JAK3
,
TYK2
💬
9.
Tofacitinib
(Xeljanz®)
×
Name
Full Name
JAK1
Janus kinase 1
JAK2
Janus kinase 2
JAK3
Janus kinase 3
TYK2
tyrosine kinase 2
37件:
AGE-RAGE signaling pathway in diabetic complications
AGE-RAGE signaling pathway in diabetic complications
,
Adipocytokine signaling pathway
,
Chemical carcinogenesis - receptor activation
,
Chemokine signaling pathway
,
Cholinergic synapse
,
Coronavirus disease - COVID-19
,
EGFR tyrosine kinase inhibitor resistance
,
Epstein-Barr virus infection
,
Growth hormone synthesis, secretion and action
,
Hepatitis B
,
Hepatitis C
,
Herpes simplex virus 1 infection
,
Human T-cell leukemia virus 1 infection
,
Human cytomegalovirus infection
,
Human papillomavirus infection
,
Influenza A
,
JAK-STAT signaling pathway
,
Kaposi sarcoma-associated herpesvirus infection
,
Leishmaniasis
,
Lipid and atherosclerosis
,
Measles
,
NOD-like receptor signaling pathway
,
Necroptosis
,
Non-small cell lung cancer
,
Osteoclast differentiation
,
PD-L1 expression and PD-1 checkpoint pathway in cancer
,
PI3K-Akt signaling pathway
,
Pancreatic cancer
,
Pathways in cancer
,
Primary immunodeficiency
,
Prolactin signaling pathway
,
Signaling pathways regulating pluripotency of stem cells
,
Th1 and Th2 cell differentiation
,
Th17 cell differentiation
,
Toxoplasmosis
,
Tuberculosis
,
Viral carcinogenesis
💬
37件:
AGE-RAGE signaling pathway in diabetic complications
,
Adipocytokine signaling pathway
,
Chemical
...
1件:
46
46
💬
9.
Tofacitinib
(Xeljanz®)
×
告示番号
日本語名
英語名
46
悪性関節リウマチ
Malignant rheumatoid arthritis
10
Tofacitinib
(Xeljanz®) 11mg Prolonged Release Tablet
1件:
Tofacitinib
Tofacitinib
(PMS-
tofacitinib
)
1件:
Tofacitinib
Tofacitinib
(
Tofacitinib
)
💬
10.
Tofacitinib
(Xeljanz®) 11mg Prolonged Release Tablet
×
Name
Other Names
Tofacitinib
Tofacitinib (USAN)
Tasocitinib
トファシチニブ
タソシチニブ
4件:
JAK1
JAK1
,
JAK2
,
JAK3
,
TYK2
💬
10.
Tofacitinib
(Xeljanz®) 11mg Prolonged Release Tablet
×
Name
Full Name
JAK1
Janus kinase 1
JAK2
Janus kinase 2
JAK3
Janus kinase 3
TYK2
tyrosine kinase 2
37件:
AGE-RAGE signaling pathway in diabetic complications
AGE-RAGE signaling pathway in diabetic complications
,
Adipocytokine signaling pathway
,
Chemical carcinogenesis - receptor activation
,
Chemokine signaling pathway
,
Cholinergic synapse
,
Coronavirus disease - COVID-19
,
EGFR tyrosine kinase inhibitor resistance
,
Epstein-Barr virus infection
,
Growth hormone synthesis, secretion and action
,
Hepatitis B
,
Hepatitis C
,
Herpes simplex virus 1 infection
,
Human T-cell leukemia virus 1 infection
,
Human cytomegalovirus infection
,
Human papillomavirus infection
,
Influenza A
,
JAK-STAT signaling pathway
,
Kaposi sarcoma-associated herpesvirus infection
,
Leishmaniasis
,
Lipid and atherosclerosis
,
Measles
,
NOD-like receptor signaling pathway
,
Necroptosis
,
Non-small cell lung cancer
,
Osteoclast differentiation
,
PD-L1 expression and PD-1 checkpoint pathway in cancer
,
PI3K-Akt signaling pathway
,
Pancreatic cancer
,
Pathways in cancer
,
Primary immunodeficiency
,
Prolactin signaling pathway
,
Signaling pathways regulating pluripotency of stem cells
,
Th1 and Th2 cell differentiation
,
Th17 cell differentiation
,
Toxoplasmosis
,
Tuberculosis
,
Viral carcinogenesis
💬
37件:
AGE-RAGE signaling pathway in diabetic complications
,
Adipocytokine signaling pathway
,
Chemical
...
1件:
46
46
💬
10.
Tofacitinib
(Xeljanz®) 11mg Prolonged Release Tablet
×
告示番号
日本語名
英語名
46
悪性関節リウマチ
Malignant rheumatoid arthritis